Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Adynamic Bone Disorder in CKD
NCT04522622Phase 4Recruiting
- Start
- Dec 2021
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in adynamic bone disease (ABD). Started Dec 2021; status: recruiting.
02
Drugs
teriparatide
03
Conditions
adynamic bone disease (ABD)
Beyond the preview
Go deeper on NCT04522622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04522622.